Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer
作者更正：p16高表达和RB1杂合缺失是ER(+)乳腺癌中CDK4/6抑制剂耐药的生物标志物。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-022-34580-3
Palafox, Marta; Monserrat, Laia; Bellet, Meritxell; Villacampa, Guillermo; Gonzalez-Perez, Abel; Oliveira, Mafalda; Brasó-Maristany, Fara; Ibrahimi, Nusaibah; Kannan, Srinivasaraghavan; Mina, Leonardo; Herrera-Abreu, Maria Teresa; Òdena, Andreu; Sánchez-Guixé, Mònica; Capelán, Marta; Azaro, Analía; Bruna, Alejandra; Rodríguez, Olga; Guzmán, Marta; Grueso, Judit; Viaplana, Cristina; Hernández, Javier; Su, Faye; Lin, Kui; Clarke, Robert B; Caldas, Carlos; Arribas, Joaquín; Michiels, Stefan; García-Sanz, Alicia; Turner, Nicholas C; Prat, Aleix; Nuciforo, Paolo; Dienstmann, Rodrigo; Verma, Chandra S; Lopez-Bigas, Nuria; Scaltriti, Maurizio; Arnedos, Monica; Saura, Cristina; Serra, Violeta
